Floatz logo

MIDAZOLAM

Neck Pain

National Center for Complementary and Integrative Health (NCCIH)Small moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Neck Pain cohort.

Asset / SponsorPhaseRating
LIDOCAINE
Ankara University
Phase 4BB
Amitryptiline
St Joseph University, Beirut, Lebanon
Phase 4BB
Xylocaine
Pain Management Center of Paducah
Phase 4BB
Celestone
Pain Management Center of Paducah
Phase 4BB
Triamcinalone
Northwestern University
Phase 4BB

View all 11 →

Same molecule, other indications

MIDAZOLAM is also rated in:

gastrointestinal stromal tumorDormant
BBB
Indicative ·
75 / 100
View asset →
neuralgiaDormant
BBB
Indicative ·
75 / 100
View asset →
epilepsyDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →